231 related articles for article (PubMed ID: 31007857)
21. The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology.
Hartmann N; Mason FE; Braun I; Pabel S; Voigt N; Schotola H; Fischer TH; Dobrev D; Danner BC; Renner A; Gummert J; Belardinelli L; Frey N; Maier LS; Hasenfuss G; Sossalla S
J Mol Cell Cardiol; 2016 May; 94():95-106. PubMed ID: 27056421
[TBL] [Abstract][Full Text] [Related]
22. Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation.
White CM; Nguyen E
Ann Pharmacother; 2017 Mar; 51(3):245-252. PubMed ID: 27758968
[TBL] [Abstract][Full Text] [Related]
23. Efficiency of ranolazine in the patient with microvascular angina, atrial fibrillation and migraine.
Osovska NY; Kuzminova NV
Wiad Lek; 2016; 69(6):832-837. PubMed ID: 28214825
[TBL] [Abstract][Full Text] [Related]
24. Ranolazine for the treatment of atrial fibrillation.
Rosa GM; Dorighi U; Ferrero S; Brunacci M; Bertero G; Brunelli C
Expert Opin Investig Drugs; 2015 Jun; 24(6):825-36. PubMed ID: 25872749
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
[TBL] [Abstract][Full Text] [Related]
26. Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation.
Burashnikov A; Antzelevitch C
Future Cardiol; 2011 Nov; 7(6):733-7. PubMed ID: 22050058
[TBL] [Abstract][Full Text] [Related]
27. The use of ranolazine in non-anginal cardiovascular disorders: A review of current data and ongoing randomized clinical trials.
Mihos CG; Krishna RK; Kherada N; Larrauri-Reyes M; Tolentino A; Santana O
Pharmacol Res; 2016 Jan; 103():49-55. PubMed ID: 26546970
[TBL] [Abstract][Full Text] [Related]
28. Ranolazine. A metabolic modulator for the treatment of chronic stable angina.
Anderson JR; Nawarskas JJ
Cardiol Rev; 2005; 13(4):202-10. PubMed ID: 15949056
[TBL] [Abstract][Full Text] [Related]
29. Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation.
Fragakis N; Koskinas KC; Katritsis DG; Pagourelias ED; Zografos T; Geleris P
Am J Cardiol; 2012 Sep; 110(5):673-7. PubMed ID: 22621799
[TBL] [Abstract][Full Text] [Related]
30. The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism.
Reiffel JA; Camm AJ; Belardinelli L; Zeng D; Karwatowska-Prokopczuk E; Olmsted A; Zareba W; Rosero S; Kowey P;
Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1048-56. PubMed ID: 26226999
[TBL] [Abstract][Full Text] [Related]
31. Ranolazine in the management of chronic stable angina.
Zerumsky K; McBride BF
Am J Health Syst Pharm; 2006 Dec; 63(23):2331-8. PubMed ID: 17106005
[TBL] [Abstract][Full Text] [Related]
32. Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review.
Dagres N; Iliodromitis EK; Lekakis JP; Simitsis P; Karatzas D; Rallidis LS; Simeonidou E; Anastasiou-Nana M
J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):254-9. PubMed ID: 24662415
[TBL] [Abstract][Full Text] [Related]
33. Update on evidence for treatment with ranolazine in stable angina.
Carbone F; Montecucco F; Mach F
Swiss Med Wkly; 2013; 143():w13874. PubMed ID: 24163124
[TBL] [Abstract][Full Text] [Related]
34. Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
Zhu H; Xu X; Fang X; Zheng J; Zhao Q; Chen T; Huang J
Clin Ther; 2019 Oct; 41(10):2137-2152.e12. PubMed ID: 31548105
[TBL] [Abstract][Full Text] [Related]
35. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
36. Ranolazine for Angina in Hypertrophic Cardiomyopathy.
Amin A; Kim B
Case Rep Cardiol; 2018; 2018():5142572. PubMed ID: 29850265
[TBL] [Abstract][Full Text] [Related]
37. New Anti-Anginal Drugs: Ranolazine.
Cavallino C; Facchini M; Veia A; Bacchni S; Rosso R; Rognoni A; Rametta F; Lupi A; Bongo AS
Cardiovasc Hematol Agents Med Chem; 2015; 13(1):14-20. PubMed ID: 25544118
[TBL] [Abstract][Full Text] [Related]
38. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
39. Role of ranolazine in angina, heart failure, arrhythmias, and diabetes.
Sossalla S; Maier LS
Pharmacol Ther; 2012 Mar; 133(3):311-23. PubMed ID: 22133843
[TBL] [Abstract][Full Text] [Related]
40. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]